Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions

Mutations in noncoding genes could play big role in regulating cancer, study finds

RNA transcribed from genes that seem not to code for anything may play an important role in regulating cancer, a new study suggests.

A number of these noncoding RNA fragments lie next to known cancer genes, the study found. Understanding how they interact with those cancer genes could open new avenues to understanding cancer’s behavior and treating it.

Led by Kannanganattu Prasanth, a University of Illinois cell and developmental biology professor, the researchers found that a certain breast cancer tumor suppressor gene needs the RNA transcribed from its opposite DNA strand to function in healthy cells. They published their work in the journal PLOS Genetics.

When a gene is expressed, the two strands of DNA unzip and one of the strands is transcribed into RNA. The RNA then travels out of the nucleus to be translated into protein. However, only a small fraction of the RNA strands are translated into proteins. The rest, called noncoding RNAs, were once thought to be “junk” but now are known to play several roles in the cell, such as regulating the expression of genes that code for proteins.

“We know a lot of the mutations in breast cancer cells happen to be on noncoding regions of the genome,” Prasanth said. “If these mutations are contributing to cancer, but are not coding for a protein, what are they doing?”

First, the researchers analyzed RNA expression in cells of a type of breast cancer known as triple-negative breast cancer, and in healthy breast cells. They found significant differences in how the cells expressed more than 1,800 long noncoding RNAs. About 500 of those were transcribed from locations on the opposite DNA strand from known protein-coding genes. Such RNAs are called “antisense,” since they are transcribed from the strand that lies opposite the coding or “sense” DNA fragment.

“Several antisense RNAs showed correlation with their neighbor protein-coding genes. Among these protein-coding genes, there are several cancer-related genes with known functions in tumor progression,” said Mahdieh Jadaliha, the first author of the paper and a recent graduate from Prasanth’s group. “The correlation between these cancer genes and their antisense RNAs could be a clue that the RNAs could potentially function in cancer progression through regulating the expression of these cancer-associated genes.”

The researchers focused on the antisense RNA to a well-studied tumor-suppressor gene called PDCD4, which is somehow deactivated in triple-negative breast cancer cells. They wondered if the reduced levels of PDCD4 antisense RNA they saw in breast cancer cells could contribute to the PDCD4 gene deactivation.

In studying the molecular mechanisms of both PDCD4 RNA and its antisense counterpart, they found that both were crucial for the PDCD4 gene to function in normal breast cells.

“We noticed that the PDCD4 antisense RNA stabilizes the protein-coding PDCD4 RNA by binding to it and protecting it from being degraded in the cell,” Prasanth said.

Without the antisense RNA, the PDCD4 RNA was degraded before it could be translated into protein. The gene could not perform its role of stopping the cancer cell from proliferating.

When the PDCD4 antisense was restored in cancer cell cultures, the cells’ growth was inhibited and they were less able to migrate and spread, the team found.

“This suggests that in patients where PDCD4 tumor suppressor activity is low, we potentially could increase its activity by activating the PDCD4 antisense RNA. In theory, we should be able to enhance the expression of the tumor suppressor in cancer cells,” Prasanth said.

The researchers say the example of PDCD4 shows that mutations in genes that seem to be noncoding could help fill in gaps in understanding cancer’s mechanisms, as well as how gene expression is regulated in the cell. Prasanth’s group members plan to study more of the antisense RNAs they identified as possibly playing a role in triple-negative breast cancer. They also plan to continue to study PDCD4 and its antisense RNA in animal models.

“This is one part of a big puzzle,” Prasanth said. “We are seeing 500 different antisense RNAs being deregulated in cancer. Thirty or 40 of them seem to be antisense to well-established tumor suppressor and oncogenes. But what about the other 460? By understanding their function, we may be able to identify new oncogenes or novel mechanisms for tumor suppression. It’s an uncharted territory, which is challenging and exciting at the same time.”


Making ‘sense’ of the ‘cart before the horse’ in mammalian cells


More information:
Mahdieh Jadaliha et al. A natural antisense lncRNA controls breast cancer progression by promoting tumor suppressor gene mRNA stability, PLOS Genetics (2018). DOI: 10.1371/journal.pgen.1007802


Provided by
University of Illinois at Urbana-Champaign

Citation:
Mutations in noncoding genes could play big role in regulating cancer, study finds (2019, March 13)
retrieved 21 March 2019
from https://medicalxpress.com/news/2019-03-mutations-noncoding-genes-big-role.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

Tagged with:

About author

Related Articles